Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Emma Taggart
Observed names:
E Taggart,
E. Taggart,
Taggart, E
Institutions:
Queen Mary University of London,
Blizard Institute
Observed institutions:
Babraham Institute,
Queen Mary University of London,
The Francis Crick Institute,
Babraham Bioscience Technologies (United Kingdom),
Kymab (United Kingdom),
Abcam (United Kingdom),
Blizard Institute,
Barts Cancer Institute
show all 8
ORCID:
0000-0002-3165-9778
Observed ORCID:
0000-0002-3165-9778
OpenAlex ID:
A5036941813
A constitutive interferon-high immunophenotype defines response to immunotherapy in colorectal cancer
2025
·
Amelia Acha-Sagredo
, Pietro Andrei
, et al.
·
Cancer Cell
·
90
An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression
2020
·
Richard C.A. Sainson
, Anil K. Thotakura
, et al.
·
Cancer Immunology Research
·
57
PDF
Abstract LB-153: KY1055, a novel ICOS-PD-L1 bispecific antibody, efficiently enhances T cell activation and delivers a potent anti-tumour response in vivo
2018
·
Richard C. Sainson
, Nahida Parveen
, et al.
·
Cancer Research
·
8
Decosus: An R Framework for Universal Integration of Cell Proportion Estimation Methods
2022
·
Chinedu A. Anene
, Emma Taggart
, et al.
·
Frontiers in Genetics
·
5
FP15 Transcriptomic and microenvironment signatures identify five molecular states and predictive signatures along the actinic keratosis to cutaneous squamous cell carcinoma progression
2026
·
Wendy Tran
, Emma Taggart
, et al.
·
British Journal of Dermatology
O1 Single-cell and spatial transcriptomics analyses reveal immune mechanisms associated with progression and metastasis in cutaneous squamous cell carcinoma
2026
·
Ankit Patel
, Nital Sumari
, et al.
·
British Journal of Dermatology
386 Single cell and spatial transcriptomics analyses reveal immune mechanisms associated with progression and metastasis in cutaneous squamous cell carcinoma
2025
·
A Patel
, N Sumaria
, et al.
·
Journal of Investigative Dermatology
PDF
1035 Understanding dynamic immune responses within a 3D microfluidic model of human skin
2023
·
S. Hindle
, E. Taggart
, et al.
·
Journal of Investigative Dermatology
PDF
Data from An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression
2023
·
Richard C.A. Sainson
, Anil K. Thotakura
, et al.
PDF
Supplementary Figures and Tables Legend from An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression
2023
·
Richard C.A. Sainson
, Anil K. Thotakura
, et al.
Supplementary Figures from An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression
2023
·
Richard C.A. Sainson
, Anil K. Thotakura
, et al.
Supplementary Movie 1 from An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression
2023
·
Richard C.A. Sainson
, Anil K. Thotakura
, et al.
Supplementary Movie 2 from An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression
2023
·
Richard C.A. Sainson
, Anil K. Thotakura
, et al.
Supplementary Table 1 from An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression
2023
·
Richard C.A. Sainson
, Anil K. Thotakura
, et al.
Supplementary Table 2 from An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression
2023
·
Richard C.A. Sainson
, Anil K. Thotakura
, et al.
Supplementary Table 2 from An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression
2023
·
Richard C.A. Sainson
, Anil K. Thotakura
, et al.
Data from An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression
2023
·
Richard C.A. Sainson
, Anil K. Thotakura
, et al.
Show more works
View as search
Works count:
18
Citation count:
160
H-index:
4
I10-index:
2
Year
Topic
Type